Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 From bench top to bedside.

× No keyword cloud information.

19 in total

1. Molecules and morphology: emerging from Plato's cave.

Authors: T S Frank
Journal: Mol Diagn Date: 2000-09

2. Farnesyltransferase inhibitors induce cytochrome c release and caspase 3 activation preferentially in transformed cells.

Authors: N Suzuki; J Urano; F Tamanoi
Journal: Proc Natl Acad Sci U S A Date: 1998-12-22 Impact factor: 11.205

3. Farnesyltransferase inhibitors induce dramatic morphological changes of KNRK cells that are blocked by microtubule interfering agents.

Authors: N Suzuki; K Del Villar; F Tamanoi
Journal: Proc Natl Acad Sci U S A Date: 1998-09-01 Impact factor: 11.205

4. Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.

Authors: Robert P Whitehead; Sheryl McCoy; John S Macdonald; Saul E Rivkin; Marcus A Neubauer; Shaker R Dakhil; Heinz-Josef Lenz; Michael S Tanaka; James L Abbruzzese
Journal: Invest New Drugs Date: 2006-07 Impact factor: 3.850

5. Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.

Authors: R W Wilkinson; E L Ross; R Poulsom; M Ilyas; J Straub; D Snary; W F Bodmer; S J Mather
Journal: Proc Natl Acad Sci U S A Date: 2001-08-21 Impact factor: 11.205

6. LC-MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation.

Authors: Mohamed W Attwa; Ali S Abdelhameed; Adnan A Kadi
Journal: Drug Des Devel Ther Date: 2021-09-15 Impact factor: 4.162

Review 7. Strategies to enhance rituximab anti-tumor activity in the treatment of CD20-positive B-cell neoplasms.

Authors: Wasif Riaz; Francisco J Hernandez-Ilizaliturri; Myron S Czuczman
Journal: Immunol Res Date: 2010-03 Impact factor: 2.829

8. Isoprenoid pathway related cascade in multiple myeloma.

Authors: Ravi kumar Kurup; Rekha A Nair; Parameswara Achutha Kurup
Journal: Pathol Oncol Res Date: 2003-07-14 Impact factor: 3.201

9. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

Authors: Bruno B Bordier; Junko Ohkanda; Ping Liu; So-Young Lee; F H Salazar; Patricia L Marion; Kazuo Ohashi; Leonard Meuse; Mark A Kay; John L Casey; Said M Sebti; Andrew D Hamilton; Jeffrey S Glenn
Journal: J Clin Invest Date: 2003-08 Impact factor: 14.808

Review 10. New p53-based anti-cancer therapeutic strategies.

Authors: K G Wiman
Journal: Med Oncol Date: 1998-12 Impact factor: 3.064